DYNAMICS OF IMMUNOLOGICAL PARAMETERS IN PATIENTS WITH SLE DURING THE YEAR AFTER VACCINATION WITH 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE

被引：0
|
作者：
Koilubaeva, G. [1 ]
Tarasova, G. [2 ]
Belov, B. [2 ]
Bolotbekova, A. [1 ]
Turatbekova, A. [1 ]
Syunbai, G. K. [1 ]
机构：
[1] Rheumatol, 3 Togolok Moldo St, Bishkek, Kyrgyzstan
[2] Rheumatol, Kashirskoye Shosse 34, Moscow, Russia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus;
D O I：
10.1136/annrheumdis-2023-eular.941
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1627
引用
收藏
页码：2047 / 2048
页数：2
相关论文
共 50 条
  • [31] The Serological Response Of Asthmatics To The 23-Valent Pneumococcal Polysaccharide Vaccine (ppsv23)
    Laratta, C. R.
    Williams, K.
    Vethanayagam, D.
    Ulanova, M.
    Vliagoftis, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [32] Impact of the national routine vaccination program on 23-valent pneumococcal polysaccharide vaccine vaccination rates in elderly persons in Japan
    Naito, Toshio
    Yokokawa, Hirohide
    Watanabe, Akira
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (06) : 496 - 498
  • [33] PHARMACOECONOMIC EVALUATION OF 13-VALENT PNEUMOCOCCAL CONJUGATE AND 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CANADIAN ADULTS
    Chuck, A.
    Waye, A.
    Zanotti, G.
    Jacobs, P.
    Kellner, J.
    Tyrrell, G.
    VALUE IN HEALTH, 2012, 15 (04) : A243 - A243
  • [34] Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    Breiman, RF
    Keller, DW
    Phelan, MA
    Sniadack, DH
    Stephens, DS
    Rimland, D
    Farley, MM
    Schuchat, A
    Reingold, AL
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2633 - 2638
  • [35] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC VASCULITIS, PRELIMINARY RESULTS
    Tarasova, G.
    Egorova, O.
    Reshetnyak, T.
    Belov, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1435 - 1435
  • [36] TOLERABILITY AND SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, PRELIMINARY RESULTS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1181
  • [37] RESPIRATORY INFECTIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS, PRIMARY AND SECONDARY AFS BEFORE AND AFTER VACCINATION WITH 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE
    Koilubaeva, G.
    Tarasova, G.
    Belov, B.
    Bolotbekova, A.
    Syunbai, K. G.
    Turatbekova, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 2070 - 2071
  • [38] 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events
    Ihara, Hiroaki
    Kikuchi, Kan
    Taniguchi, Hiromi
    Fujita, Shogo
    Tsuruta, Yuki
    Kato, Motoyasu
    Mitsuishi, Yoichiro
    Tajima, Ken
    Kodama, Yuzo
    Takahashi, Fumiyuki
    Takahashi, Kazuhisa
    Azuma, Nakanobu
    VACCINE, 2019, 37 (43) : 6447 - 6453
  • [39] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Benin, A
    O'Brien, K
    Watt, J
    Reid, R
    Zell, ER
    Katz, S
    Donaldson, C
    Parkinson, A
    Schuchat, A
    Santosham, M
    Whitney, CG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1148 - 1148
  • [40] Immune response to the 23-valent pneumococcal polysaccharide vaccine in lymphoma patients and patients with chronic renal diseases
    Kuhnemund, O
    Stutz, A
    Fuchshuber, A
    Querfeld, U
    Petrasch, S
    Reinert, RR
    Lutticken, R
    STREPTOCOCCI AND THE HOST, 1997, 418 : 837 - 839
12345